Insights

FDA cleared niche BrainScope has FDA-cleared biomarkers for mild brain injury assessment, highlighting a proven regulatory path and strong validation in emergency departments. This suggests a sales opportunity to expand adoption in EDs, concussion clinics, and personal injury settings where reducing unnecessary CTs is valuable.

AI driven outcomes The company leverages AI-powered EEG analysis to deliver objective brain health biomarkers. Target buyers should include hospitals and clinics seeking radiation-free, rapid triage tools, with emphasis on cost-effectiveness and streamlined patient flow.

Expansion momentum Recent leadership changes and strategic hires (CEO appointment, VP of Sales) indicate a growth-focused trajectory and increased commercial momentum. This presents an opening for enterprise agreements with health systems and payers looking for scalable neurodiagnostic solutions.

Strategic partnerships With a focus on expanding indications such as early Alzheimer’s detection, ARIA assessment, and rapid stroke evaluation, there are cross-sell opportunities into neurology, radiology, geriatrics, and military health programs seeking advanced biomarkers and multi-disease brain health insights.

Market readiness A revenue range of 10–25 million and a track record of reducing unnecessary head CTs and emergency department stays position BrainScope as a validated value driver for health systems aiming to improve outcomes and reduce costs, making it attractive for broader deployment and payer conversations.

Similar companies to BrainScope

BrainScope Tech Stack

BrainScope uses 8 technology products and services including LinkedIn Ads, HubSpot Content Hub, Squarespace, and more. Explore BrainScope's tech stack below.

Media & News

BrainScope's Email Address Formats

BrainScope uses at least 3 email formats:
BrainScope Email FormatsExamplePercentage
First.Last@brainscope.comJohn.Doe@brainscope.com
96%
FirstL@brainscope.comJohnD@brainscope.com
3%
First.Middle@brainscope.comJohn.Michael@brainscope.com
1%

Frequently Asked Questions

What is BrainScope's phone number?

Minus sign iconPlus sign icon
You can contact BrainScope's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BrainScope's official website and social media links?

Minus sign iconPlus sign icon
BrainScope's official website is brainscope.com and has social profiles on LinkedIn.

How much revenue does BrainScope generate?

Minus sign iconPlus sign icon
As of October 2026, BrainScope's annual revenue is estimated to be $10M - $25M.

What is BrainScope's NAICS code?

Minus sign iconPlus sign icon
BrainScope's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does BrainScope have currently?

Minus sign iconPlus sign icon
As of October 2026, BrainScope has approximately 34 employees across 2 continents, including North America and Asia. Key team members include Member Board Of Directors: C. R., Ph.D. Chief Scientific Officer: L. P. and Vice President, Sales & Commercial Development: D. W. Explore BrainScope's employee directory with LeadIQ.

What industry does BrainScope belong to?

Minus sign iconPlus sign icon
BrainScope operates in the Medical Equipment Manufacturing industry.

What technology does BrainScope use?

Minus sign iconPlus sign icon
BrainScope's tech stack includes LinkedIn Ads, HubSpot Content Hub, Squarespace, Artifactory, Microsoft 365, GitLab, Adobe Creative Suite and Piwik PRO Core.

What is BrainScope's email format?

Minus sign iconPlus sign icon
BrainScope's email format typically follows the pattern of First.Last@brainscope.com. Find more BrainScope email formats with LeadIQ.

How much funding has BrainScope raised to date?

Minus sign iconPlus sign icon
As of October 2026, BrainScope has raised $87M in funding. The last funding round occurred on Sep 19, 2023.

When was BrainScope founded?

Minus sign iconPlus sign icon
BrainScope was founded in 2010.
BrainScope logo

BrainScope

Medical Equipment ManufacturingMaryland, United States11-50 Employees

Brainscope Company Inc. is a Rockville, Maryland-based medical device company focused on neurotechnology that analyzes brain electrical activity to generate objective insights about brain health. Its platform accepts EEG data from any source and leverages machine learning to produce biomarkers that are rapid, radiation-free, accessible, and cost-effective, expanding the clinical utility of traditional EEG.

The company developed an FDA-cleared device for head-injury assessment and was the first neurology device cleared under the FDA’s AI/Machine Learning-Enabled Medical Device category. Its FDA-cleared biomarkers for mild brain injury (concussions and brain bleeds) have been deployed in major U.S. health systems, with reported reductions in unnecessary head CTs and shorter emergency department stays. In May 2026, BrainScope announced the appointment of David Wingate as Vice President of Sales and Commercial Operations, as the company continues expanding its commercial momentum and exploring additional biomarkers for conditions such as early Alzheimer’s detection, ARIA assessment, stroke evaluation, concussion subtyping, and military blast exposure.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $87M

    BrainScope has raised a total of $87M of funding over 13 rounds. Their latest funding round was raised on Sep 19, 2023 as a Series B.

  • $10M - $25M

    BrainScope's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.